Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ The Ensign Group, Inc. (ENSG) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Medical Care Facilities
$175.39
-2.58 (-1.45%)Did ENSG Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Ensign Group is one of their latest high-conviction picks.
Based on our analysis of 12 Wall Street analysts, ENSG has a bullish consensus with a median price target of $206.00 (ranging from $200.00 to $220.00). The overall analyst rating is Strong Buy (8.8/10). Currently trading at $175.39, the median forecast implies a 17.5% upside. This outlook is supported by 4 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from A.J. Rice at UBS, projecting a 25.4% upside. Conversely, the most conservative target is provided by David Macdonald at Truist Securities, suggesting a 14.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ENSG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 14, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $206.00 |
| Nov 10, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $200.00 |
| Nov 5, 2025 | Stephens & Co. | Raj Kumar | Overweight | Maintains | $200.00 |
| Nov 5, 2025 | UBS | A.J. Rice | Buy | Maintains | $220.00 |
| Sep 2, 2025 | UBS | A.J. Rice | Buy | Maintains | $205.00 |
| Aug 14, 2025 | UBS | A.J. Rice | Buy | Maintains | $195.00 |
| Jul 28, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $165.00 |
| Jul 28, 2025 | Stephens & Co. | Raj Kumar | Overweight | Maintains | $170.00 |
| May 2, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $156.00 |
| Feb 7, 2025 | Stephens & Co. | Raj Kumar | Overweight | Maintains | $160.00 |
| Feb 6, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $155.00 |
| Feb 4, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $166.00 |
| Jan 6, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $155.00 |
| Nov 21, 2024 | UBS | A.J. Rice | Buy | Initiates | $175.00 |
| Oct 28, 2024 | Stephens & Co. | Scott Fidel | Overweight | Maintains | $167.00 |
| Oct 28, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $172.00 |
| Oct 28, 2024 | Truist Securities | David Macdonald | Hold | Maintains | $170.00 |
| Oct 25, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $168.00 |
| Oct 21, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $167.00 |
| Sep 16, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $165.00 |
The following stocks are similar to Ensign Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
The Ensign Group, Inc. has a market capitalization of $10.16B with a P/E ratio of 31.8x. The company generates $4.83B in trailing twelve-month revenue with a 6.8% profit margin.
Revenue growth is +19.8% quarter-over-quarter, while maintaining an operating margin of +7.4% and return on equity of +17.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides senior living and healthcare services.
The company operates skilled nursing and rehabilitative care facilities, generating revenue through the management and development of these establishments. Additionally, it offers hospice care, physical therapy, and home health services, allowing it to serve a comprehensive range of elder care needs and enhance its profitability.
Ensign Group maintains facilities across multiple states, highlighting its commitment to accessible healthcare solutions. The company focuses on optimizing operational efficiencies in its facilities, which supports its strategic growth and positively influences patient care standards in the elder care sector.
Healthcare
Medical Care Facilities
39,300
Mr. Barry R. Port
United States
2007
Ensign Group (ENSG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ENSG adds four skilled nursing facilities across Colorado, Arizona and Kansas, pushing its total healthcare operations to 373 nationwide.
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Ensign Group, Inc. acquired two skilled nursing facilities in Colorado: a 103-bed facility in Wheat Ridge and a 69-bed facility in Lakewood, effective December 1, 2025, under a long-term lease.
The Ensign Group's acquisition of skilled nursing facilities expands its portfolio, potentially boosting revenue and market presence, which can positively impact stock performance.
Ensign Group (ENSG) reported earnings 30 days ago; investors should monitor upcoming developments and performance indicators for potential stock movements.
Earnings reports can influence stock price and investor sentiment. Upcoming developments may affect Ensign Group's performance and market positioning, impacting investment decisions.
Ensign Group (Nasdaq: ENSG) acquired Willow Point Rehabilitation and Nursing Center, a 45-bed skilled nursing facility in Kansas City, expanding its healthcare services portfolio.
The acquisition of Willow Point Rehabilitation and Nursing Center expands Ensign Group's footprint, potentially increasing revenue streams and enhancing its market position in healthcare services.
The Ensign Group, Inc. acquired Santa Rosa Care Center, a 144-bed skilled nursing facility in Tucson, Arizona, under a long-term, triple net lease.
Ensign Group's acquisition of Santa Rosa Care Center expands its service portfolio and real estate assets, potentially increasing revenue and market presence in the senior care sector.
ENSG has expanded its healthcare operations by acquiring four skilled nursing facilities in Colorado, Arizona, and Kansas, bringing its total to 373 facilities across the U.S.
ENSG's expansion to 373 facilities signals growth potential, enhancing revenue streams and market presence, which may positively impact stock performance and investor confidence.
Ensign Group (ENSG) is being evaluated for its potential as a top stock pick for momentum investors. Further insights may clarify its investment viability.
The inquiry into Ensign Group's potential as a momentum stock signals investor interest, which could drive demand and influence pricing trends, impacting market sentiment.
Based on our analysis of 12 Wall Street analysts, The Ensign Group, Inc. (ENSG) has a median price target of $206.00. The highest price target is $220.00 and the lowest is $200.00.
According to current analyst ratings, ENSG has 4 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $175.39. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ENSG stock could reach $206.00 in the next 12 months. This represents a 17.5% increase from the current price of $175.39. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates skilled nursing and rehabilitative care facilities, generating revenue through the management and development of these establishments. Additionally, it offers hospice care, physical therapy, and home health services, allowing it to serve a comprehensive range of elder care needs and enhance its profitability.
The highest price target for ENSG is $220.00 from A.J. Rice at UBS, which represents a 25.4% increase from the current price of $175.39.
The lowest price target for ENSG is $200.00 from David Macdonald at Truist Securities, which represents a 14.0% increase from the current price of $175.39.
The overall analyst consensus for ENSG is bullish. Out of 12 Wall Street analysts, 4 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $206.00.
Stock price projections, including those for The Ensign Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.